Hepatic Fibrosis in HCV, Non Invasive and Economical Biochemical Markers, A Review!

International Journal of Medical Science

© 2015 by SSRG - IJMS Journal

Volume 2 Issue 10

Year of Publication : 2015

Authors : K.M.D.S Panag, Gitanjali, Anil Batta and Jasmeet Singh

10.14445/23939117/IJMS-V2I10P103

How to Cite?

K.M.D.S Panag, Gitanjali, Anil Batta and Jasmeet Singh, "Hepatic Fibrosis in HCV, Non Invasive and Economical Biochemical Markers, A Review!," SSRG International Journal of Medical Science, vol. 2,  no. 10, pp. 13-15, 2015. Crossref, https://doi.org/10.14445/23939117/IJMS-V2I10P103

Abstract:

Hepatitis is a medical condition defined by the inflammation of the liver and characterized by the presence of inflammatory cells in the tissue of the organ.By using Non- invasive biomarkers there is significant decrease in discomfort and risks and there can befrequent re-evaluation, objective interpretation and easy patient acceptance as compared to invasive markers in which there is higher cost along with intra and inter-observer variability.

Keywords:

Hepatitis, Liver Biopsy, Non- invasive Biomarkers & Invasive biomarkers.

References:

[1]. Online Entomology Dictionary, Entomology.com, Retrived , 26/8/2012.
[2]. Bernal W and Wendon J, Acute Liver Failure, New England Journal Of Medicine,2013 369(26):2525-2534.
[3]. Longo, DL, Fauci AS, Kasper DL, Tumors of the liver and Biliary tree , Harrison Principles of Internal Medicine, 2012 18th edition, Chapter 92.
[4]. Ryder S, Beckingham I, Acute hepatitis, British Medical Journal,2001, 322(7279) 151-153.
[5]. Rauff, Bisma, Idress, Mahummad, Shah, Hepatitis Associated Aplastic anemia, Virology Journal, 2001 8(1), 87.
[6]. Hepatitis B Transmission, US Centre for disease control and prevention, Retrived21,11,2014.
[7]. Longo DL, Chronic Hepatitis, Harrison Principle’s of Internal Medicine, New York Chapter 306, 18th edition, 2012.
[8]. Longo DL, Acute Viral Hepatitis, Harrison’s Principle of Internal Medicine, Chapter 305, 18th edition, 2012. 9. AymanKhedr, Samir Sabry, IJAE, 2011 Vol (2): Issue(3), 107-116
[10]. Leonardo de lucca et al, World Journal of Gastroenterology,2014;20(11):2854-2866
[11]. Javed khan, Farooq Khan, Mohammad Dilawar, JCPSP, 2007, Vol 17 (6)323-326.
[12]. Green RM, Flamn S, “AGA Technical Review on the evaluation of liver Chemistry tests”, Gastroenterology,2002, 123(4):1367-84.
[13]. Pratt DS, Kaplan, Evolution of abnormal liver enzymes results in asymptomatic patients, New England Journal of Medicine,2000,342(17), 1266-71.
[14]. Mohammad Abdullah, AliasgharPouri, Bio lmpacts, 2015,5(1),17-23
[15]. Poynard T, Morra R, Halfon P etal, Meta analysis of Fibrotest diagnostic Value in Chronic Liver Disease, BMC Gastroenterology 2007,7,40.
[16]. Patel K, Nelson DR, Rocky DC, correlation of Fibrospect 2 with Histological and morphometric evaluation of liver fibrosis in Chronic Hepatitis C, Clinical Gastoenterology, Hepatiol,2008,6:242-247.
[17]. Kalantri H, Hoseini H, Babak A, Validation of Hepascore as a Predictor of liver Fibrosis in patients with Chronic Hepatitis C infection, Hapat Res Treat , 2011.
[18]. Rosenberg WM, Voelker M, Thiel R, serum markers detect the presence of liver fibrosis: A Cohort Study, Gastroenterology, 2004;127:1704-1713.
[19]. Cales P, Oberty F, Michalak S, A novel panel of blood markers to access the degree of liver Fibrosis. Hepatology, 2005;42:1373-1381.
[20]. Chou R, Wasson N, Blood test to diagnose Fibrosis or Cirrhosis in patients with Chronic Hepatitis C Virus infection: A Systematic Review. Ann Intern Med 2013;158:807-820.